Nextgen Biomed Ltd (NXGN.TA)

ILA 60.3

(-9.19%)

EBITDA Summary of Nextgen Biomed Ltd

Nextgen Biomed Ltd's latest annual EBITDA in 2023 was -5.24 Million ILS , up 38.35% from previous year.
Nextgen Biomed Ltd's latest quarterly EBITDA in 2023 FY was N/A , up 38.35% from previous quarter.
Nextgen Biomed Ltd reported an annual EBITDA of -8.5 Million ILS in 2022, down -236.86% from previous year.
Nextgen Biomed Ltd reported an annual EBITDA of -2.52 Million ILS in 2021, down -94.91% from previous year.
Nextgen Biomed Ltd reported a quarterly EBITDA of N/A for 2023 FY, up 38.35% from previous quarter.
Nextgen Biomed Ltd reported a quarterly EBITDA of -1.71 Million ILA for 2022 Q2, down 0.0% from previous quarter.

Annual EBITDA Chart of Nextgen Biomed Ltd (2023 - 2013)

Historical Annual EBITDA of Nextgen Biomed Ltd (2023 - 2013)

Year	EBITDA	EBITDA Growth
2023	-5.24 Million ILS	38.35%
2022	-8.5 Million ILS	-236.86%
2021	-2.52 Million ILS	-94.91%
2020	-1.29 Million ILS	-6.67%
2019	-1.24 Million ILS	-0.41%
2018	-1.21 Million ILS	19.55%
2017	-1.5 Million ILS	17.04%
2016	-1.81 Million ILS	58.65%
2015	-4.38 Million ILS	-1.27%
2014	-4.32 Million ILS	47.82%
2013	-8.29 Million ILS	0.0%

Year	EBITDA	EBITDA Growth
2023 Q2	- ILA	0.0%
2023 FY	- ILS	38.35%
2022 Q2	-1.71 Million ILA	0.0%
2022 FY	- ILS	-236.86%
2022 Q4	-1.86 Million ILA	0.0%
2021 Q4	-1.48 Million ILA	0.0%
2021 FY	- ILS	-94.91%
2021 Q2	-1.34 Million ILA	0.0%
2020 FY	- ILS	-6.67%
2020 Q4	-596 Thousand ILA	0.0%
2020 Q2	-731 Thousand ILA	0.0%
2019 FY	- ILS	-0.41%
2019 Q2	-464 Thousand ILA	0.0%
2019 Q4	-777 Thousand ILA	0.0%
2018 FY	- ILS	19.55%
2017 FY	- ILS	17.04%
2016 FY	- ILS	58.65%
2015 FY	- ILS	-1.27%
2014 FY	- ILS	47.82%
2013 FY	- ILS	0.0%

Peer EBITDA Comparison of Nextgen Biomed Ltd

Name	EBITDA	EBITDA Difference